prax-114
Small moleculeexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
1
Phase 4
0
Earliest trial started Mar 30, 2021 (NCT04832425)
Timeline
2020s
- Jan 1, 2021
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Gamma-amino-N-butyrate transaminaseMODULATOR
ABAT modulator
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05387642 | Phase 2 | Apr 5, 2022 | Praxis Biologics |
| NCT05260541 | Phase 2 | Jan 25, 2022 | Praxis Biologics |
| NCT04969510 | Phase 2 | Jun 24, 2021 | Praxis Biologics |
| NCT04832425 | Phase 2/Phase 3 (Phase 3) | Mar 30, 2021 | Praxis Biologics |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Praxis Biologics | For profit | 4 | 4 | 2 | 2021 |
1 organizations
Page 1 / 1